Integrative transcriptomic, molecular dynamic simulation and in vitro analysis identify Evodiamine as a multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer.
- DOI
- 10.1007/s13205-026-05107-0
- Published
- 2026 Nov
- Container
- 3 Biotech
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13205-026-05107-0,
title = {Integrative transcriptomic, molecular dynamic simulation and in vitro analysis identify Evodiamine as a multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer.},
author = {Patra SK and Rajeshwari R and Barik K and Kumar A and Biswal BK},
year = {2026},
journal = {3 Biotech},
doi = {10.1007/s13205-026-05107-0},
url = {https://doi.org/10.1007/s13205-026-05107-0}
}RIS
TY - JOUR TI - Integrative transcriptomic, molecular dynamic simulation and in vitro analysis identify Evodiamine as a multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer. AU - Patra SK AU - Rajeshwari R AU - Barik K AU - Kumar A AU - Biswal BK PY - 2026 JO - 3 Biotech DO - 10.1007/s13205-026-05107-0 UR - https://doi.org/10.1007/s13205-026-05107-0 ER -
APA
SK, P., R, R., K, B., A, K., & BK, B. (2026). Integrative transcriptomic, molecular dynamic simulation and in vitro analysis identify Evodiamine as a multi-target therapeutic agent against cisplatin-resistant non-small cell lung cancer.. 3 Biotech. https://doi.org/10.1007/s13205-026-05107-0
Source records
- pubmed · retrieved 2026-11-10T11:34:39.682Z